PATENT CLAIM ANALYSIS

Application Number: 16221546
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "374000"]

Abstract:
The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

Claim (Index 17):
The method of  claim 3 , wherein the therapeutically effective amount is from about 50 mg to about 500 mg per day.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 98.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14715143', '15608507', '16004666', '15592727', '10943549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8178709532740259
- 35 USC 102 Novelty (BERT): 0.5722261250796907
- Combined Prediction Score: 0.7933064704545925
- Mean Citation Score: 404.270682
- Max Citation Score: 466.64432
- Similarity Product: 391.52617675807

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test